Mapping of the significant modulated genes within Reactome pathways database tool. by Lucia Natarelli (823310)

Ionotropic GABAergic neurotransmission decreases retinal microglia dendritic morphology and process dynamics. by Aurora M. Fontainhas (232472)

“…Overall process velocity was increased with GABAergic blockade with bicuculline and decreased with GABA application. All significant changes (p<0.05) are indicated by an asterisk (*).…”

The combination of LPS and PFC caused faster clot initiation and decreased clot strength. by Heather F. Pidcoke (9023789)

“…Both SAL-PFC12 and LPS-PFC3 are significantly decreased from BL levels (*, p < .05); SAL-PFC12 is significantly different from SAL-SAL control (†, p < .05). …”

Rimonabant significantly decreases the overall responses of plasma lipid classes. by Chunxiu Hu (186733)

AtCaM4 decreases GSNOR activity in response to salt stress. by Shuo Zhou (1320660)

Combined Quantitative (Phospho)proteomics and Mass Spectrometry Imaging Reveal Temporal and Spatial Protein Changes in Human Intestinal Ischemia–Reperfusion by Anna M. Kip (11804493)

Subjects:

Chemokines and cytokines are decreased in wound fluids from mice with pulmonary IAV infection. by Meredith J. Crane (145147)

Inflammation is not sufficient to account for decreased relative bacterial numbers in higher dose infection. by Matthew Calverley (109776)

“…D) CCR2 KO animals exhibited a significant decrease in the number of recruited Ly6c+/CD11b+/CD11c+ monocytes at day 9 PI in high dose infection. …”

Predictive value of RVT1 for the decreased RV ejection fraction (RVEF) and poor outcome in pulmonary arterial hypertension (PAH). by Ryotaro Asano (11767131)

“…(c) The receiver characteristics curve analysis for a decreased RVEF at follow-up. We defined a change of +3% or −3% (between baseline and follow-up over 12 months) as an increased or decreased RVEF, respectively. …”

Mst1^−/− mice exhibit decreased incidence and severity of CIA. by Konstantin V. Salojin (567844)

Pitfalls of merging only considering end-points. by Almiqdad Elzein (13141038)

Fig 2 - by Madison Luick (17539007)

Subjects:

Proportion of non-sugar sweeteners used in eligible and exempt drinks over time. by Madison Luick (17539007)

Subjects:

Fig 1 - by Madison Luick (17539007)

Subjects:

Volume in mL of drinks, classified as either control or the levy group in which they were in last observed in the dataset. by Madison Luick (17539007)

Subjects:

Price per 100mL of drinks, classified as either control or the levy group they were in last in the dataset. by Madison Luick (17539007)

Subjects:

Intracellular K⁺ decreases during pectoral fin bud growth. by Xiaowen Jiang (8291814)

Inclusion of SRRM4-regulated exons is decreased in tumors and cancer cell lines. by Sarah A. Head (6066398)

“…<p>(A) Distribution of ΔPSIs of differentially spliced SRRM4 target exons between normal and tumor samples in the TCGA datasets. Only exons with significant changes (q < 0.01, |ΔPSI| ≥ 5) are shown. …”

Renal (urea and creatinine) (a, b) and Liver function (ALT and AST) (c, d) test in serums of different experimental groups and body weight changes (e) on day 10. by Omid Mehrpour (9385929)

Subjects:

Join-point regression analysis of the statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)